Monoclonal antibodies targeting CD38 in hematological malignancies and beyond

Niels W. C. J. van de Donk; Maarten L. Janmaat; Tuna Mutis; Jeroen J. Lammerts van Bueren; Tahamtan Ahmadi; A. Kate Sasser; Henk M. Lokhorst; Paul W. H. I. Parren

doi:https://doi.org/10.1111/imr.12389

Monoclonal antibodies targeting CD38 in hematological malignancies and beyond

Niels W. C. J. van de Donk, Maarten L. Janmaat, Tuna Mutis, Jeroen J. Lammerts van Bueren, Tahamtan Ahmadi, A. Kate Sasser, Henk M. Lokhorst, Paul W. H. I. Parren

Research output: Contribution to journal › Article › Academic › peer-review

259 Citations (Scopus)

Original language	English
Pages (from-to)	95-112
Journal	Immunological reviews
Volume	270
Issue number	1
DOIs	https://doi.org/10.1111/imr.12389
Publication status	Published - Mar 2016

Keywords

CD38
cancer
daratumumab
isatuximab
multiple myeloma
therapeutic antibody

Access to Document

https://doi.org/10.1111/imr.12389

Cite this

@article{2e697527872e4f05a80a983490e4972b,

title = "Monoclonal antibodies targeting CD38 in hematological malignancies and beyond",

keywords = "CD38, cancer, daratumumab, isatuximab, multiple myeloma, therapeutic antibody",

author = "{van de Donk}, {Niels W. C. J.} and Janmaat, {Maarten L.} and Tuna Mutis and {van Bueren}, {Jeroen J. Lammerts} and Tahamtan Ahmadi and Sasser, {A. Kate} and Lokhorst, {Henk M.} and Parren, {Paul W. H. I.}",

year = "2016",

month = mar,

doi = "https://doi.org/10.1111/imr.12389",

language = "English",

volume = "270",

pages = "95--112",

journal = "Immunological reviews",

issn = "0105-2896",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Monoclonal antibodies targeting CD38 in hematological malignancies and beyond

AU - van de Donk, Niels W. C. J.

AU - Janmaat, Maarten L.

AU - Mutis, Tuna

AU - van Bueren, Jeroen J. Lammerts

AU - Ahmadi, Tahamtan

AU - Sasser, A. Kate

AU - Lokhorst, Henk M.

AU - Parren, Paul W. H. I.

PY - 2016/3

Y1 - 2016/3

KW - CD38

KW - cancer

KW - daratumumab

KW - isatuximab

KW - multiple myeloma

KW - therapeutic antibody

U2 - https://doi.org/10.1111/imr.12389

DO - https://doi.org/10.1111/imr.12389

M3 - Article

C2 - 26864107

SN - 0105-2896

VL - 270

SP - 95

EP - 112

JO - Immunological reviews

JF - Immunological reviews

IS - 1

ER -